tykhr
sign in
free sign up
PhaseBio Pharmaceuticals Inc
Biotechnology
Healthcare
PHAS
48.13 M shares
NASDAQ US
traded
08 Aug 2022
listed
yes
open
1.38
52 week high
4.60
high
1.38
52 week low
1.32
low
1.29
growth
-58.13 %
previous Close
1.35
P/E ratio
market cap
44.07 M
div yield
0
usd
Mar 2022
qoq
revenue
117 K
101.10 %
net incoming
-11.14 M
-112.68 %
eps
0.00 %
74.44 %
eps surprise
65.15 %
net profit margin
-9522.22 %
-8698.00 %
operating incoming
-18.23 M
-124.25 %
net change in cash
-23.11 M
-58.77 %
cash on hand
18.69 M
-55.29 %
cost of revenue
0.00 %
top